Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Cuprizone neurotoxicity in the rat: morphologic observations.
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Episode 35 with Dr. Daniel Reich on neuroradiology in MS
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Keystone Symposium: Dendritic Cells and Macrophages Reunited
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
MS clinical trials: what can subgroup analyses teach us?
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Assessment and Imaging of the Cerebrovascular Glycocalyx.
Masitinib mesylate application for conditional approval
The quality of reports of randomized trials in multiple sclerosis: a review.
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.

Pages